Automated systems maker Omnicell Inc. (NASDAQ: OMCL) is acquiring Aesynt from Francisco Partners for $275 million.

Aesynt, based in Cranberry Township, Pennsylvania, manufactures robots and automatic dispensers of medications that are designed to increase efficiency, accuracy and reduce costs for more than 1,200 health care facilities. The target has an annual Ebitda of about $20 million and $182 million in revenue. Francisco bought Aesynt in 2013, when it purchased McKesson Corp.’s automation unit. Aesynt purchased Health Robotics in 2014.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.